NDC 10702-223 – Atovaquone Oral Suspension
Atovaquone 750 mg/5mL · Suspension · Oral
Product NDC10702-223
Product details
- Brand name
- Atovaquone Oral Suspension
- Generic name
- Atovaquone
- Labeler
- KVK-Tech, Inc.
- Dosage form
- Suspension
- Route
- Oral
- Marketing category
- ANDA · ANDA210510
- Marketed since
- March 29, 2019
- Listing expires
- December 31, 2027
- Pharmacologic class
- Antimalarial; Antiprotozoal
Active ingredients
- Atovaquone 750 mg/5mL
Uses, dosage, side effects and warnings for Atovaquone Oral Suspension →
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 10702-223-21 | 1 BOTTLE, PLASTIC in 1 CARTON (10702-223-21) / 210 mL in 1 BOTTLE, PLASTIC | Mar 29, 2019 |
Recalls mentioning this NDC
- D-0772-2021 Sep 1, 2021 · Class I
Temperature abuse: the firm received customer complaints of unusual grittiness in the product.
Other Atovaquone Oral Suspension products
- 81033-105 Atovaquone 750 mg/5mL · Suspension · Kesin Pharma Corporation